Ondansetron augmentation for the management of obsessive-compulsive disorder in a patient with treatment-resistant schizophrenia
published in: Australian and New Zealand Journal of Psychiatry
date of publication: 2020-10-07
main subject: schizophrenia, obsessive-compulsive disorder
Cites articles
There is nothing here
Article - wd:Q100488296